Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004880064 | SCV005535956 | uncertain significance | not specified | 2024-11-15 | criteria provided, single submitter | clinical testing | The c.1829G>T (p.R610L) alteration is located in exon 16 (coding exon 16) of the AXL gene. This alteration results from a G to T substitution at nucleotide position 1829, causing the arginine (R) at amino acid position 610 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |